Quince Therapeutics, Inc.QNCXNASDAQ
Loading
Current Ratio Over TimeCompressed
Percentile Rank14
3Y CAGR-8.3%
5Y CAGR-12.7%
Studio
Year-over-Year Change

Current ratio (current assets / current liabilities)

3Y CAGR
-8.3%/yr
vs +16.4%/yr prior
5Y CAGR
-12.7%/yr
Recent acceleration
Acceleration
-24.7pp
Decelerating
Percentile
P14
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
2 yr
Consecutive declineCompressed
PeriodValueYoY Change
20246.05-25.2%
20238.09-73.5%
202230.55+289.0%
20217.85-3.2%
20208.11-32.0%
201911.93-76.1%
201849.82+1065.3%
20174.28-